Supplier of high-quality cannabinoids, Open Book Extracts, is expanding its operations into Europe with the establishment of OBX Europe.
Based in North Carolina, Open Books Extracts is on a path of global expansion. Through the establishment of OBX Europe, the company will be able to fulfill regional orders of all sizes, serving as a borderless gateway to the European cannabinoid market. The company recently established OBX Asia, headquartered in Hong Kong, and selected Peter Bodill Agencies as its principal distribution partner in South Africa.
Logistics and supply chain professional, Najeeb Qazizada, will serve as director of supply chain for OBX Europe, located in Almere outside Amsterdam. Locating the main distribution centre in the Netherlands will allow the company to support local warehousing of its ingredients and finished goods in Europe to create supply chain efficiencies for the its UK and European clients. It will also offer additional options for contract manufacturing in the UK and Europe.
Qazizada commented: “With the demand for cannabinoids products in Europe growing rapidly, it is paramount for leading brands to have a reputable, quality supplier like Open Book Extracts.
“OBX is cGMP certified, a member of EIHA and its Novel Food Consortium, and is well versed in international market distribution and regulations, ensuring that we will meet the UK and European market demand for high quality, safe cannabinoid products.”
The company’s 76,000 sqft, cGMP-certified research and production facility near Durham, North Carolina, enables the manufacture of cannabinoids including CBD, CBN, CBC, CBG, CBGa, CBT, CBDa, CBDv, and THCv.
OBX joined the European Industrial Hemp Associations’ (EIHA) Novel Food Consortium in March 2021, and is now joining forces with other companies to pursue safety studies to provide safe and ready access to cannabinoid-based products throughout the UK and EU.
“Quality and consistency are paramount in the European market, and we are committed to bringing the highest quality standards to the European cannabinoid market and beyond,” said Dave Neundorfer, OBX CEO.
“The establishment of an on-the-ground presence helps us provide the best service and support to current customers in the region as well as new ones that understand the tremendous opportunity in this burgeoning market.”